GJC2

Chr 1ARAD

gap junction protein gamma 2

Also known as: CX46.6, Cx47, GJA12, HLD2, LMPH1C, LMPHM3, PMLDAR, SPG44

This gene encodes a gap junction protein. Gap junction proteins are members of a large family of homologous connexins and comprise 4 transmembrane, 2 extracellular, and 3 cytoplasmic domains. This gene plays a key role in central myelination and is involved in peripheral myelination in humans. Defects in this gene are the cause of autosomal recessive Pelizaeus-Merzbacher-like disease-1. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismAR/ADLOEUF 1.233 OMIM phenotypes
Clinical SummaryGJC2
🧬
Gene-Disease Validity (ClinGen)
hypomyelinating leukodystrophy 2 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
77 unique Pathogenic / Likely Pathogenic· 241 VUS of 432 total submissions
📖
GeneReview available — GJC2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.23LOEUF
pLI 0.010
Z-score 1.17
OE 0.54 (0.261.23)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
1.87Z-score
OE missense 0.67 (0.590.76)
173 obs / 257.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.54 (0.261.23)
00.351.4
Missense OE?0.67 (0.590.76)
00.61.4
Synonymous OE?0.94
01.21.6
LoF obs/exp: 4 / 7.4Missense obs/exp: 173 / 257.5Syn Z: 0.52
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateGJC2-related lymphatic malformationOTHERAD
definitiveGJC2-related leukodystrophy, hypomyelinatingOTHERAR

This gene — mechanism propensity

DN
0.78top 25%
GOF
0.87top 5%
LOF
0.2873th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFSome patients showed reduced nerve conduction velocities, which indicated the presence of a mild peripheral demyelinating motor neuropathy, predominantly of the lower limbs, consistent with GJA12 expression in sural and sciatic nerve tissue. Since Gjb1 and Gja12 are functionally redundant in mice, U1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 15192806

ClinVar Variant Classifications

432 submitted variants in ClinVar

Classification Summary

Pathogenic32
Likely Pathogenic45
VUS241
Likely Benign82
Benign7
Conflicting23
32
Pathogenic
45
Likely Pathogenic
241
VUS
82
Likely Benign
7
Benign
23
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
25
7
0
0
32
Likely Pathogenic
30
13
2
0
45
VUS
6
226
4
5
241
Likely Benign
0
4
7
71
82
Benign
0
0
4
3
7
Conflicting
23
Total612501779430

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

35 pathogenic / likely-pathogenic (of 44) ClinVar copy-number / structural variants overlap GJC2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GJC2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →